Mezavant XL launched for ulcerative colitis

Shire has launched Mezavant XL (mesalazine), indicated for the induction of clinical and endoscopic remission in patients with mild to moderate, active ulcerative colitis and for the maintenance of remission.

Mezavant is available as 1200mg gastro-resistant prolonged-release tablets. The recommended dose for induction of remission is two to four tablets taken once daily with food.

The highest dose of four tablets daily is recommended for patients not responding to lower doses of mesalazine. When using the highest dose, the effect of the treatment should be evaluated at eight weeks.

The recommended dose for maintenance of remission is two tablets taken once daily.

 

Further information: Shire 01256 894000

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

An elderly woman with one arm in a plaster cast sits resting both hands on her walker

Doctors urge NICE to reverse decision on new osteoporosis drug

More than NHS 100 clinicians have called on NICE to...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Image of both strengths of Seffalair Spiromax inhaler side by side.

New salmeterol/fluticasone dry powder inhaler for asthma

Seffalair Spiromax is the sixth dry powder salmeterol/fluticasone...

An older man in a blue shirt and beige trousers leans forward on a sofa rubbing his painful lower back. Promoted
MIMSconnect

Established muscle relaxant offers new approach to managing back pain

Sponsored by Mibe Pharma

A muscle relaxant that has been used for decades outside the UK may provide an alternative to current treatments for low back pain, explains Dr Sunny Nayee, consultant in anaesthesia and pain medicine at Imperial College NHS Healthcare Trust.

Sponsored by Mibe Pharma UK Ltd. UK/MYO/21/044; December 2021.

Click here to view prescribing information for Myopridin® (pridinol mesilate)